Lemaitre Vascular (LMAT) Tops Q4 EPS by 2c, provides guidance

Lemaitre Vascular (NASDAQ: LMAT) reported Q4 EPS of $0.68, $0.02 better than the analyst estimate of $0.66. Revenue for the quarter came in at $64.45 million versus the consensus estimate of $62.98 million.

GUIDANCE:

Lemaitre Vascular sees Q1 2026 revenue of $65.6-67.6 million, versus the consensus of $65.85 million.

Lemaitre Vascular sees FY2026 revenue of $276-284 million, versus the consensus of $270.5 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• L3Harris CEO steps down amid conduct review, shares drop
• Is Treasury selloff a major issue for stock market bulls?